Medical Utilization and Antibiotics Use of Prostatitis Patients in Korea.
10.24304/kjcp.2018.28.2.117
- Author:
Boram LEE
1
;
Yoon Jung CHOI
;
Younsong CHOI
;
Nayoung KONG
;
Minsun CHOI
Author Information
1. Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.
- Publication Type:Original Article
- Keywords:
Antibiotics;
fluoroquinolone;
medical utilization;
prostatitis
- MeSH:
Anti-Bacterial Agents*;
Ciprofloxacin;
Disease Management;
Humans;
Insurance, Health;
Korea*;
Length of Stay;
Levofloxacin;
National Health Programs;
Outpatients;
Pelvic Pain;
Prescriptions;
Prostate;
Prostatitis*
- From:Korean Journal of Clinical Pharmacy
2018;28(2):117-123
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Prostatitis, one of the most common diseases of the prostate, is a complex disease with various clinical features. This study aims to analyze the utilization and prescribing patterns of antibiotics in Korean patients with prostatitis between 2008 and 2015. METHODS: We used the National Health Insurance Database complied from the Health Insurance Review and Assessment Service (HIRA). The outcomes included the number of claims, number of patients, medical cost, and length of stay for each year. In addition, the prescribing patterns of antibiotics, including fluoroquinolone, and low-dose use of ciprofloxacin and levofloxacin were investigated. RESULTS: The total number of patients and medical cost increased by 9.5% and 51.7% from 2008 to 2015, respectively. Most prostatitis patients were classified as chronic prostatitis patients. The prescribing proportion of antibiotics for chronic prostatitis outpatients decreased from 71.0% to 66.9% from 2008 to 2015, and fluoroquinolone accounted for more than half of the total antibiotics. Over 80% of prescription of levofloxacin and ciprofloxacin was identified to be for low-dose use. CONCLUSION: Most of the patients with prostatitis experienced pain relief and condition improvement after antibiotic treatment; however, chronic prostatitis and chronic pelvic pain syndrome recur easily. Therefore, active disease management and further studies are needed to enhance our understanding of effective treatment for prostatitis.
